Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| VICAL INC | 145,649 | reported | 01 Apr 2013 | tx 15+794,169−90,491 |
| aTYR PHARMA INC | 37,296 | reported | 04 Feb 2026 | tx 38+1,589,787−23,518 |
| Otonomy, Inc. | 27,500 | reported | 21 Jun 2022 | tx 2+62,500 |
| TALPHERA, INC. | 25,600 | reported | 23 Oct 2025 | tx 10+140,653 |
| Cue Biopharma, Inc. | 24,400 | reported | 02 Jan 2026 | tx 2+73,200 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Feb 2026 | EXERCISE | aTYR PHARMA INC | 3,750 | — | |
| 04 Feb 2026 | SALE | aTYR PHARMA INC | 1,558 | 0.98 USD | |
| 03 Feb 2026 | EXERCISE | aTYR PHARMA INC | 3,750 | 0.00 USD | deriv |
| 09 Jan 2026 | GRANT_AWARD | aTYR PHARMA INC | 412,500 | 0.00 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | Cue Biopharma, Inc. | 24,400 | 0.00 USD | deriv |
| 23 Oct 2025 | GRANT_AWARD | TALPHERA, INC. | 4,267 | 0.00 USD | |
| 23 Oct 2025 | GRANT_AWARD | TALPHERA, INC. | 25,600 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | Cue Biopharma, Inc. | 48,800 | 0.00 USD | deriv |
| 03 Feb 2025 | EXERCISE | aTYR PHARMA INC | 3,750 | — | |
| 04 Feb 2025 | SALE | aTYR PHARMA INC | 1,254 | 3.78 USD | |
| 03 Feb 2025 | EXERCISE | aTYR PHARMA INC | 3,750 | 0.00 USD | deriv |
| 08 Jan 2025 | GRANT_AWARD | aTYR PHARMA INC | 275,000 | 0.00 USD | deriv |
| 24 Jun 2024 | GRANT_AWARD | TALPHERA, INC. | 2,174 | 0.00 USD | |
| 24 Jun 2024 | GRANT_AWARD | TALPHERA, INC. | 13,044 | 0.00 USD | deriv |
| 31 May 2024 | PURCHASE | aTYR PHARMA INC | 5,000 | 1.79 USD | first after silence |
| 05 Feb 2024 | EXERCISE | aTYR PHARMA INC | 3,750 | — | |
| 06 Feb 2024 | SALE | aTYR PHARMA INC | 1,590 | 1.69 USD | |
| 05 Feb 2024 | EXERCISE | aTYR PHARMA INC | 3,750 | 0.00 USD | deriv |
| 05 Jan 2024 | GRANT_AWARD | aTYR PHARMA INC | 150,000 | 0.00 USD | deriv |
| 10 Oct 2023 | GRANT_AWARD | TALPHERA, INC. | 581 | 0.00 USD | |
| 10 Oct 2023 | GRANT_AWARD | TALPHERA, INC. | 3,487 | 0.00 USD | deriv |
| 16 Feb 2023 | GRANT_AWARD | aTYR PHARMA INC | 84,023 | 0.00 USD | deriv |
| 03 Feb 2023 | EXERCISE | aTYR PHARMA INC | 3,750 | — | |
| 06 Feb 2023 | SALE | aTYR PHARMA INC | 1,566 | 2.36 USD | |
| 03 Feb 2023 | EXERCISE | aTYR PHARMA INC | 3,750 | 0.00 USD | deriv |
5 purchases reported after at least 12 months of silence — most recent on 31 May 2024.